Repeated Low-Level Red-Light for Myopia Control

Review of Myopia Management: The Latest in Red Light Therapy

https://reviewofmm.com/the-latest-in-red-light-therapy/

Key Concepts: RLRL for Myopia Control

1. What is Repeated Low-Level Red-Light (RLRL) Therapy?
   A treatment involving brief daily exposure (typically a few minutes, twice daily) to red light (~650 nm) ➝ aims to mimic the benefits of outdoor bright light exposure by stimulating retinal pathways that slow down myopia progression. en.wikipedia.org+10reviewofmm.com+10visionmonday.com+10
   
   

2. Mechanism of Action
   RLRL is a form of photobiomodulation, believed to enhance choroidal blood flow and mitochondrial energy production, promoting increased dopamine release in the retina—which signals the eye to reduce axial elongation (lengthening). reviewofoptometry.com+5scholars.duke.edu+5journals.lww.com+5journals.lww.com
   
   

3. Clinical Evidence (Key Trials & Reviews):
   
   

   • Standalone RLRL: Meta-analysis of ~1,700 participants shows significant reduction in axial length (AL) and refractive error (SER) compared to standard single-vision spectacles over long-term (up to 2 years) scholars.duke.edu+9pubmed.ncbi.nlm.nih.gov+9ajo.com+9.
     
     

   • RLRL vs Ortho-K Lenses: A 138-child, 2-year study showed AL growth around 0.17 mm (RLRL) vs 0.50 mm (Ortho-K). Early regression of AL observed in 55% of RLRL users after 1 month; 42% sustained that improvement at 1 year journals.lww.com+1reviewofoptometry.com+1.
     
     

   • RLRL + Orthokeratology: Combined therapy produced average AL change of –0.02 mm vs +0.27 mm in Ortho-K alone after 12 months, suggesting additive benefits en.wikipedia.org+7reviewofmm.com+7journals.lww.com+7.
     
     

4. Efficacy Highlights:
   
   

   • Short-term: 55% of children showed AL shortening after one month; sustained in 42% at 12 months journals.lww.com+1reviewofoptometry.com+1.
     
     

   • Year 1: AL growth ~0.03 mm with RLRL vs ~0.28 mm with Ortho-K;
     
     

   • Year 2: RLRL users averaged 0.14 mm growth, still less than Ortho-K's 0.21 mm .
     
     

5. Safety & Side Effects
   
   

   • RLRL is generally well tolerated in children—no serious retinal damage reported in 2-year studies.
     
     

   • Some caution over potential retinal exposure parameters; standards and protocols continue to evolve journals.lww.com.
     
     

   • “Rebound” effect possible when stopping treatment, requiring more long-term follow-up .
     
     

6. Unanswered Questions & Research Needs
   
   

   • Optimal treatment duration, wavelength, and device standardization need refinement.
     
     

   • Long-term effects, rebound after cessation, use in early/pre-myopia children—all require more investigation reviewofmm.comen.wikipedia.org+10scholars.duke.edu+10journals.lww.com+10.
     
     

 Bottom Line

• RLRL therapy is an emerging, promising technique to slow or even reverse myopia progression in children, with efficacy sometimes surpassing orthokeratology lenses.
  
  

• It is convenient, non-invasive, and shows sustained benefits in early use.
  
  

• Further high-quality research is needed to finalize treatment guidelines, safety protocols, and its long-term role, including potential synergy with optical therapies like Ortho-K.

EyePower Red is a simple affordable device for home use, developed by the continual research of UK ophthalmologist & team.  Use for only 3 minutes preferably before 10 AM (it has an auto-shut off function) daily or several times a week to recharge your eyes.  

Using red-light therapy is only one aspect of your eye health.   Proper eye habits reducing technology screen and device usage, good stress/sleep management and making researched-backed practical dietary changes will make a difference between optimal & suboptimal/compromised eye function.

Use our link for more information and to purchase.   EyePower Red is a medical device and not available from Amazon.  Prices are in CAD (shipped from the UK, taxes and duties apply from Canada Post).

https://www.eye-power.co.uk/?aff=22

Although scientific studies have shown promising results from PBM Red light therapy, results will vary by individual.  The goal of red light therapy is meant to help slow down the progression of Dry AMD Macular Degeneration, improvement of vision is not guaranteed.  The use of red light therapy at home as a wellness device DOES NOT replace routine examinations & treatments by your eye doctor plus the need for daily balanced nutrient-dense diet, outdoor light exposure, rest/exercise, & lifestyle changes.